PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Coverage · Medical Policy · Neurology, Pain Management, Family Medicine +2 moreMedium impact

MA05.071, Remote Electrical Neuromodulation for Migraines

Act
by Jan 1, 2026
Effective date
Jan 1, 2026
Identified
Sep 17, 2026

Summary

Independence Blue Cross reissued MA05.071 with no substantive changes to Remote Electrical Neuromodulation (REN/Nerivio) coverage for migraine prevention. The policy establishes medical necessity criteria for adults (18+) and pediatric patients (8-17) with 6-24 headache days per 28-day period, requiring either failed preventive medications, pregnancy/breastfeeding status, medication overuse headache risk, or drug-drug interaction concerns. Acute migraine treatment remains non-covered (experimental/investigational). Billing teams must ensure claims comply with these eligibility criteria and HCPCS code A4540 is used for device billing.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

by Jan 1, 2026 · 8 steps
01Billing team must implement claims review procedures to verify REN device requests meet MA05.071 medical necessity criteria before submission.
02Ensure providers document patient age (18+ for adults; 8-17 for pediatric), ICHD-3 migraine diagnosis confirmation, and headache frequency (6-24 days per 28-day period for 3 consecutive months).
03Verify at least one of four additional criteria is met: failure/contraindication/intolerance to ≥2 guideline-recommended preventive medications (anticonvulsants, antihypertensives, antidepressants, CGRP inhibitors), pregnancy/breastfeeding/conception planning, medication overuse headache risk, or drug-drug interaction risk.
04Use HCPCS code A4540 with appropriate migraine ICD-10 codes (G43.001, G43.009, G43.011, G43.019, G43.101, G43.109, G43.111, G43.119).
05Flag and deny any claims for acute migraine treatment (non-covered as experimental/investigational).
06For continued use, require documentation of compliance and clinical benefit.
07Failure to verify criteria will result in claim denials.
08Update billing software rules and encounter templates to include required documentation fields.

Codes mentioned

A4540G43.001G43.009G43.011G43.019G43.101G43.109G43.111G43.119

Original notice

MA05.071, Remote Electrical Neuromodulation for Migraines
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account